-
Product Insights
Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) – Drugs In Development, 2023
Global Markets Direct’s, ‘Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) - Drugs In Development, 2023’, provides an overview of the Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...